Trending...
- New Dad Battles Leukemia and Wins!
- Tarp Supply Inc.® Prepares to Celebrate 21 Years of Excellence in the Tarps Industry
- Inked & Maxim Model Teisha Mechetti Turns Heads—And Builds Community Impact
To become the premier provider of internationally sourced, affordable prescription medications for health plans and individuals, Care2Care International is now offering an equity crowdfunding opportunity through TycoonInvest.
PORTSMOUTH, N.H. - illiNews -- Care2Care International (C2C) is striving to provide value to healthcare plans and individual patients, and its growth potential is significant. This is why we asked our partner TycoonInvest to help us raise $400,000 to create jobs, expand our marketing reach, further develop our patient platform, and invest in sourcing partnerships.
C2C provides international pharmacy mail-order services, and is striving to help patients in the United States fully and easily exercise their right to import prescription drugs for personal use, individually or through their health plan.
To this end, C2C provides a simple solution for procuring US FDA-approved medications delivering huge savings for hundreds of costly prescription drugs.
During the last decade, drug prices have increased by 84%, outpacing any other medical commodity or service. While brand and specialty drug prices are now 3 to 5 times higher than in other developed countries, this gap continues to grow rapidly! Despite many formal announcements in the last years, no real reform has been put in place and none is realistically in sight.
More on illi News
Meanwhile, every year, over 4 million Americans buy their drugs for personal use abroad. Their rights of importing medications for personal use are protected by Congress, which reiterated its will as recently as 2018, as part of the Opioid Bill.
Contracting with brick-and-mortar pharmacies in Canada and European countries, Care2Care provides easy access via a patient portal. The pharmacies deliver the medications through mail-order, a solution many Americans are now accustomed to.
C2C's interests are completely aligned with their clients' as shown by the moderate, win-win performance fee which is a function of the actual savings generated: the more the client saves, the more C2C gets paid.
Care2Care target market is the employer self-funded health plans, whose drug spending represents now roughly 25% of their total costs and is the fastest-growing item. These plans are therefore in dire need of real cost containment solutions.
C2C markets its services directly to employers directly or partnering with consultants, brokers, or providers sharing the same values: deliver a fair and high-value service to American people in search of real solutions for their health needs, at an affordable and transparent cost.
More on illi News
Care2Care is proud to announce a strategic partnership with an innovative, transparent, 100% pass-through PBM, expanding C2C's offer and expertise to the full pharmacy benefit management. This new service called Care2Care Choice Rx™ will allow C2C to reach out to employers with a comprehensive pharmacy solution to achieve the lowest net cost reference price. At stake: for the employer, a potential cost reduction of 40%+ of Rx expenditures, meaning 10%+ of total health care plan spending; for Care2Care, another revenue stream from a broader range of clients.
Making it safe and easy, Care2care International ambitions to become the premier provider of internationally sourced affordable prescription medications for health plans and individuals while promoting a comprehensive cost-effective pharmacy solution for everyone.
For more information about our Reg CF Offering, visit the investment platform at https://tycooninvest.com/care2care.
C2C provides international pharmacy mail-order services, and is striving to help patients in the United States fully and easily exercise their right to import prescription drugs for personal use, individually or through their health plan.
To this end, C2C provides a simple solution for procuring US FDA-approved medications delivering huge savings for hundreds of costly prescription drugs.
During the last decade, drug prices have increased by 84%, outpacing any other medical commodity or service. While brand and specialty drug prices are now 3 to 5 times higher than in other developed countries, this gap continues to grow rapidly! Despite many formal announcements in the last years, no real reform has been put in place and none is realistically in sight.
More on illi News
- Cynthia Pinot Among Artists Selected for Renowned London Art Biennale 2025
- Real Estate Experts Highlight Jersey Shore as a Smart Buy in 2025
- Spur Chicago Announces "Mindfulness in eMOTION" Workshop
- Don't Get Left In The Dark: Duracell Urges Americans To Gear Up For A Stormier-Than-Average Season
- $18 Price Target Issued in New Research Report After $34 Million Revenue Forecast from Acquisition; $101.5 Million Net Revenue in 2025; NAS DAQ: IQST
Meanwhile, every year, over 4 million Americans buy their drugs for personal use abroad. Their rights of importing medications for personal use are protected by Congress, which reiterated its will as recently as 2018, as part of the Opioid Bill.
Contracting with brick-and-mortar pharmacies in Canada and European countries, Care2Care provides easy access via a patient portal. The pharmacies deliver the medications through mail-order, a solution many Americans are now accustomed to.
C2C's interests are completely aligned with their clients' as shown by the moderate, win-win performance fee which is a function of the actual savings generated: the more the client saves, the more C2C gets paid.
Care2Care target market is the employer self-funded health plans, whose drug spending represents now roughly 25% of their total costs and is the fastest-growing item. These plans are therefore in dire need of real cost containment solutions.
C2C markets its services directly to employers directly or partnering with consultants, brokers, or providers sharing the same values: deliver a fair and high-value service to American people in search of real solutions for their health needs, at an affordable and transparent cost.
More on illi News
- West Dentistry Welcomes New Oral Surgeon to Enhance Patient Care
- The AML Shop Launches New Financial Investigations Unit, Appoints Director to Lead the Initiative
- Raidium révolutionne le diagnostic de la Sclérose en Plaques en partenariat avec l'Hôpital Fondation Adolphe de Rothschild
- New Podcast "Spreading the Good BUZZ" Hosted by Josh and Heidi Case Launches July 7th with Explosive Global Reach and a Mission to Transform Lives
- The Herbal Care, Led by Markel Bababekov, Becomes a Top Dispensary in NYC's Upper East Side
Care2Care is proud to announce a strategic partnership with an innovative, transparent, 100% pass-through PBM, expanding C2C's offer and expertise to the full pharmacy benefit management. This new service called Care2Care Choice Rx™ will allow C2C to reach out to employers with a comprehensive pharmacy solution to achieve the lowest net cost reference price. At stake: for the employer, a potential cost reduction of 40%+ of Rx expenditures, meaning 10%+ of total health care plan spending; for Care2Care, another revenue stream from a broader range of clients.
Making it safe and easy, Care2care International ambitions to become the premier provider of internationally sourced affordable prescription medications for health plans and individuals while promoting a comprehensive cost-effective pharmacy solution for everyone.
For more information about our Reg CF Offering, visit the investment platform at https://tycooninvest.com/care2care.
Contact
Pascal Orliac
Co-founder and Chief Marketing Officer
www.care2careinternational.com
pascal@care2caremedicaltravel.com
+1 603 781-4947
Pascal Orliac
Co-founder and Chief Marketing Officer
www.care2careinternational.com
pascal@care2caremedicaltravel.com
+1 603 781-4947
Source: Care2Care International
Filed Under: Business
0 Comments
Latest on illi News
- Infinite Health Introduces Cutting-Edge Regenerative Medicine for Wound Care with Trip Goolsby, MD
- Tarp Supply Inc.® Prepares to Celebrate 21 Years of Excellence in the Tarps Industry
- Top Dentist Concord CA, Smile Makers Dental Care, Celebrates 500 5-Star Reviews
- Bio-Inspired Technology-Dynamic and Adaptable for unknown real-world environments
- ALIVE and KICKING: LAUGHTER NEVER GETS OLD has its World Premiere July 11-20 in St. Charles, IL
- AAR to announce fourth quarter fiscal year 2025 results on July 16, 2025
- Michael Reafsnyder opens solo exhibition at Scott Richards Contemporary Art in San Francisco
- Valley Sleep Therapy Expands to Prescott with New Location at Crossings Road
- New Dad Battles Leukemia and Wins!
- Kefir Comes to NASCAR as Lifeway Foods Races into Hometown Weekend with Driver Josh Bilicki at The Loop 110
- Recession-Proof Startups: What Business Plans Investors Are Actually Funding in 2025
- $17.4 Million Total Revenue for First Half of 2025 (up 31.8% YOY) for Global Wet Trades Services Provider with High Value Bitcoin Investments
- $12.8 Million Net Revenue for 2024 for Cloud-Based Crowdsourcing Recruitment and SaaS-Enabled HR Solutions Provider: Baiya International Group Inc
- City of Chicago Releases Annual Comprehensive Financial Report for Fiscal Year 2024
- Indies United is pleased to present our July 2025 book releases
- Endurance Warranty Earns 2025 Buyer's Choice Awards from ConsumerAffairs Through Verified Customer Reviews
- Hire Virtue Announces Executive Sponsorship Opportunity for Houston Hiring Blitz & Job Fair on August 6, 2025
- Inked & Maxim Model Teisha Mechetti Turns Heads—And Builds Community Impact
- Naperville: Structure Fire in the 1600 Block of Country Lakes Drive
- Plan to Launch Silo Technologies' Cybersecurity Pilot Program for Ultimate Nationwide Deployment via Exclusive Partnership: Stock Symbol: BULT